Patent ID: 9505798
Filing Date: 2016-11-29
CPC Classification: A61K,C07J

Claim Text:
1. A method for treating or ameliorating in a mammal a disease or condition that is causally related to RORγt activity in vivo, wherein the disease or condition is arthritis, diabetes, multiple sclerosis, uveitis, psoriasis, asthma, bronchitis, allergic rhinitis, chronic obstructive pulmonary disease, atherosclerosis, H. pylori infections, ulcers, inflammatory bowel disease, Crohn's disease, ulcerative colitis, sprue, food allergies or, experimental autoimmune encephalomyelitis (EAE), which comprises administering to the mammal an effective disease-treating or condition-treating amount of a compound according to formula III: wherein Y is CO each R each subscript n is independently 0, 1, 2, 3, 4, or 5; and each dotted bond is independently a single or a double bond; or a pharmaceutically acceptable salt, solvate or prodrug thereof;